JB-170

N/A

Report date: 2022/12/28 16:54:38
NME

Base Information

Drug NameJB-170
Drug Alias NameJB-170
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionSerine/threonine-protein kinase Aurora-A inhibitorsProteolysis
TargetsSerine/threonine-protein kinase Aurora-A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Würzburg
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Würzburg
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A